CN Patent

CN117177744A — Cdk2抑制剂及其使用方法

Assigned to Cedilla Treatment Co ltd · Expires 2023-12-05 · 2y expired

What this patent protects

本公开提供了化合物、其组合物以及将其用于抑制CDK2和治疗CDK2相关疾病和障碍的方法。

USPTO Abstract

本公开提供了化合物、其组合物以及将其用于抑制CDK2和治疗CDK2相关疾病和障碍的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN117177744A
Jurisdiction
CN
Classification
—
Expires
2023-12-05
Drug substance claim
No
Drug product claim
No
Assignee
Cedilla Treatment Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.